In spite of all the positive news releases of late, page-2

Tes,
Its pretty clear from the last ann or two, that the SP is very closely tracking ARV because of the immense potential (or not) of the conglomerate gold distribution, particularly when in contact with the bassalt cap. So while there is an underlying component based around the existing resource and potential to access plant via the various agreements, its very much the conglomerate/bassalt story that's the tail wagging the dog. So its just a hang in there and enjoy the ride story wrt SP, on the understanding, that if you don't buy in too high, this old dog might eventually end up in production with around 2 MOz (ignoring the conglomerate story at present), making the current SP kinda ok. And of course, any good news on the broader conglomerate field is likely to be a great boost. All eyes are on ARV and NOVO for their first bulk assays due in three weeks or so, decent grades and new understanding there will attract significant international interest methinks.